Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 39

Results For "Active"

1251 News Found

Granules India update on USFDA inspection at Gagillapur facility
News | December 05, 2024

Granules India update on USFDA inspection at Gagillapur facility

Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA


Ann-Xiaoyan Li appointed Group CFO and MD of Romaco Group
People | December 04, 2024

Ann-Xiaoyan Li appointed Group CFO and MD of Romaco Group

She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding


Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor
Medical Device | November 25, 2024

Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor

The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs


IMCD expands its Pharmaceuticals Technical Centre in Jakarta
Supply Chain | November 23, 2024

IMCD expands its Pharmaceuticals Technical Centre in Jakarta

The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards


Shilpa Pharma Lifesciences received CEP from EDQM for API, Octreotide
Drug Approval | November 19, 2024

Shilpa Pharma Lifesciences received CEP from EDQM for API, Octreotide

Octreotide is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis


IOL Chemicals and Pharmaceuticals posts Q2 FY25 PT at Rs. 19 Cr
News | November 16, 2024

IOL Chemicals and Pharmaceuticals posts Q2 FY25 PT at Rs. 19 Cr

Total Income in Q2 FY25 stood at Rs. 532.18 crore


Solvay and Pantys join forces to advance menstrual health and sustainability
Healthcare | November 15, 2024

Solvay and Pantys join forces to advance menstrual health and sustainability

Donation drive in São Paulo aims to support 250 young women’s health and environmental responsibility


AstraZeneca invests US$ 3.5 billion in R&D and manufacturing in US
News | November 14, 2024

AstraZeneca invests US$ 3.5 billion in R&D and manufacturing in US

This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs


Cupid Q2 FY25 income up 29.7%; PAT up 96.2%
News | November 13, 2024

Cupid Q2 FY25 income up 29.7%; PAT up 96.2%

Net Profit was at Rs. 10.04 crore, as compared to Rs. 5.12 crore in Q2 FY24, clocking a growth of 96.22%


Granules India’s Unit V facility secures USFDA EIR with NAI status
Drug Approval | November 10, 2024

Granules India’s Unit V facility secures USFDA EIR with NAI status

The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit